Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jul 07, 2016 $1.79 $1.81 $1.72 $1.78 45 000
Jul 06, 2016 $1.77 $1.80 $1.72 $1.78 170 100
Jul 05, 2016 $1.81 $1.88 $1.70 $1.79 257 100
Jul 01, 2016 $1.71 $1.92 $1.70 $1.83 520 000
Jun 30, 2016 $1.71 $1.75 $1.68 $1.70 252 600
Jun 29, 2016 $1.76 $1.76 $1.65 $1.69 174 400
Jun 28, 2016 $1.75 $1.78 $1.65 $1.73 147 600
Jun 27, 2016 $1.90 $1.91 $1.66 $1.73 249 100
Jun 24, 2016 $1.75 $1.89 $1.75 $1.89 332 900
Jun 23, 2016 $1.86 $1.89 $1.77 $1.83 264 200
Jun 22, 2016 $1.89 $1.90 $1.80 $1.83 233 700
Jun 21, 2016 $2.10 $2.10 $1.78 $1.89 1 038 500
Jun 20, 2016 $1.90 $2.34 $1.83 $2.00 4 596 300
Jun 17, 2016 $1.78 $1.80 $1.68 $1.68 71 400
Jun 16, 2016 $1.77 $1.82 $1.67 $1.76 176 958
Jun 15, 2016 $1.76 $1.83 $1.74 $1.79 95 950
Jun 14, 2016 $1.78 $1.79 $1.68 $1.74 194 811
Jun 13, 2016 $1.75 $1.83 $1.68 $1.78 163 096
Jun 10, 2016 $1.66 $1.73 $1.59 $1.65 80 664
Jun 09, 2016 $1.79 $1.81 $1.69 $1.70 102 630
Jun 08, 2016 $1.86 $1.86 $1.78 $1.81 94 515
Jun 07, 2016 $1.65 $1.87 $1.61 $1.86 248 581
Jun 06, 2016 $1.62 $1.68 $1.55 $1.65 252 117
Jun 03, 2016 $1.57 $1.64 $1.54 $1.62 260 282
Jun 02, 2016 $1.52 $1.65 $1.52 $1.57 255 792
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT